Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis (2019)
- Authors:
- Autor USP: ULIANA, SILVIA RENI BORTOLIN - ICB
- Unidade: ICB
- DOI: 10.1016/j.ijpddr.2019.06.003
- Subjects: PARASITOLOGIA; LEISHMANIOSE CUTÂNEA ANIMAL; FARMACOCINÉTICA; ADJUVANTES IMUNOLÓGICOS; IMUNOPARASITOLOGIA; FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal for Parasitology: Drugs and Drug Resistance
- ISSN: 2211-3207
- Volume/Número/Paginação/Ano: v. 11, p. 106-117, 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
CARIDHA, Diana et al. Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis. International Journal for Parasitology: Drugs and Drug Resistance, v. 11, p. 106-117, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ijpddr.2019.06.003. Acesso em: 03 out. 2024. -
APA
Caridha, D., Vesely, B., Bocxlaer, K. van, Arana, B., Mowbray, C. E., Rafati, S., et al. (2019). Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis. International Journal for Parasitology: Drugs and Drug Resistance, 11, 106-117. doi:10.1016/j.ijpddr.2019.06.003 -
NLM
Caridha D, Vesely B, Bocxlaer K van, Arana B, Mowbray CE, Rafati S, Uliana SRB, Reguera R, Deitrick MK, Sciotti R, Buffet P, Croft SL. Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis [Internet]. International Journal for Parasitology: Drugs and Drug Resistance. 2019 ; 11 106-117.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijpddr.2019.06.003 -
Vancouver
Caridha D, Vesely B, Bocxlaer K van, Arana B, Mowbray CE, Rafati S, Uliana SRB, Reguera R, Deitrick MK, Sciotti R, Buffet P, Croft SL. Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis [Internet]. International Journal for Parasitology: Drugs and Drug Resistance. 2019 ; 11 106-117.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ijpddr.2019.06.003 - Characterization of Tbmeta1 and 2, T. brucei homologues of the Leishmania infective-stage specific meta proteins.
- Mapping and characterization of the Leishmania (L.) amazonensis genomic region containing the meta 1 gene:: comparative study with the L. (L.) major genome.
- Characterization of nod-like genes in Leishmania
- The meta 2 gene of Leishmania: structural characterisation and expression
- Identification of sequences related to the meta 1 gene in trypanosomatids
- Structure and function of a stage-regulated gene in Leishmania
- Caracterização molecular de uma proteína rica em sequencias repetidas de leucina em Leishmania braziliensis
- In Vitro and In Vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis
- Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major
- The meta 2 gene:: genomic comparison in trypanosomatids and characterization of the meta 2 protein of Leishmania (L) amazonensis.
Informações sobre o DOI: 10.1016/j.ijpddr.2019.06.003 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | Route map for the discove... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
